Video
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Beacon Therapeutics completes enrollment in phase 2/3 VISTA trial
3 Things You Should Know About Interventional Glaucoma Comanagement
Boehringer Ingelheim launches phase 2 study of oral therapy for diabetic macular edema
Patient-Centered Treatment Strategies in the Management of nAMD and DME
PER-001 shows vision restoration in glaucoma and DR in phase 2a trials
4DMT accelerating 4D-150 4FRONT phase 3 program, laying off 25% of staff